Nifedipine–lopinavir/ritonavir severe interaction: a case report-Reference-Cited by-同舟云学术

Nifedipine–lopinavir/ritonavir severe interaction: a case report

Published:2007-01-02 Issue:1 Volume:21 Page:119-120
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Baeza María T,Merino Esperanza,Boix Vicente,Climent Eduardo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference3 articles.

1. Potent inhibition of the cytochome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: a positive drug–drug interaction;Kumar;Drug Metab Dispos,1999

2. Lopinavir/ritonavir (ABT-378/r);Qazi;Exp Opin Pharmacother,2002

3. Kaletra;Corbett;Ann Pharmacother,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A CYP3A4 Drug-Drug Interaction Between Nirmatrelvir/Ritonavir and Nifedipine Leading to Edema, Oliguria, and Acute Kidney Injury: A Case Report;Annals of Pharmacotherapy;2022-12-22

2. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2;Journal of Controlled Release;2021-09

3. Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients;PLOS ONE;2021-05-11

4. Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs;European Journal of Clinical Pharmacology;2021-01-16

5. Investigating the interaction between nifedipine‐ and ritonavir‐containing antiviral regimens: A physiologically based pharmacokinetic/pharmacodynamic analysis;British Journal of Clinical Pharmacology;2020-12-29